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Abstract
OBJECTIVE: To study the effect of Qilongtoutong
granule (QLTT) on plasma calcitonin gene-related
peptide (CGRP), beta-endorphin (β-EP), 5-HT, dopa-
mine (DA), noradrenalin (NE), and blood viscosity in
migraine model rats and mice.
METHODS: Both the acute blood stasis model
group and nitroglycerin-induced migraine model
group included 60 Sprague-Dawley rats. The reser-
pine-reduced model group had 60 Kunming mice.
Rats from each test were grouped into normal con-
trol group, model group, Zhengtian pill (ZTP)
group, and high, moderate, or low-dose QLTT
groups. In the acute blood stasis model test, after
gavage for 7 days, rats were given 0.8 mL/kg adren-
aline hydrochloride subcutaneously twice, and
kept in ice water for 5 min. After fasting for 12 h,
rats were anesthetized and blood samples were col-
lected for detection of blood viscosity. In the nitro-
glycerin-induced migraine group, after gavage for
7 days, rats were intraperitoneally injected nitro-
glycerin (10 mg/kg), and 4 h later, blood samples
were collected from postcava for measuring the
plasma CGRP and β-EP levels. In the reserpine-re-
duced model test, except the normal control
group, mice were administered reserpine (0.25 mg/
kg, i.h.) for 9 days. Mice received intragastric admin-
istration from the third day to the ninth day. One
hour after the last gavage, blood and brain tissue
samples were obtained. Then, blood clotting time
and the contents of neurotransmitters were deter-
mined.
RESULTS: QLTT- (3.6, 1.8, and 0.9 g/kg) and
ZTP-treated rats had lower blood viscosity than
that in model rats under different shear rates (P<
0.01). QLTT- (3.6, 1.8 g/kg) and ZTP-treated rats had
significantly lower plasma CGRP levels and higher
plasma β-EP levels than those in model rats (P<
0.01). QLTT treatment at dose of 0.9 g/kg had lower
plasma CGRP levels as well (P<0.05). QLTT- (5.2,
2.6 g/kg) and ZTP-treated mice had longer blood
clotting time than that in model mice (P<0.01).
QLTT- (2.6 g/kg) and ZTP-treated mice had higher
plasma serotonin (5-HT) levels than those in model
mice (P<0.05).
CONCLUSION: QLTT-treated animals had lower
plasma CGRP level, higher plasma β-EP, 5-HT, high-
er brain tissue 5-HT, NE, DA levels, and lower blood
viscosity than those in the migraine model animals.
© 2014 JTCM. All rights reserved.
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INTRODUCTION
Migraine is a common disease that adversely affects
quality of life.1 However, few migraine medications
achieve an effective rate over 50% and side effects limit
their use.2 Therefore, it is clinically significant to seek
new drugs for migraine. A Chinese medicine formula
for the treatment of migraine, Qilongtoutong granule
(QLTT), has been used in clinic over 50 years.
According to the theory of Traditional Chinese Medi-
cine (TCM), the stagnation of Qi and blood may bring
about pain. Therefore, activating blood, expelling
blood stasis, and dredging collaterals are the principles
for migraine management. Research indicates that calci-
tonin gene-related peptide (CGRP) is responsible for
neurogenic inflammation and vasodilatation of the cra-
nial vessels in migraine pathophysiology.3 Some schol-
ars found that beta-endorphin (β-EP), by modulating
the release of sympathetic transmitters, played a role in
the pathogenesis of migraine.4 Research also showed
that a fall of serotonin (5-HT) in plasma and brain tis-
sue was a specific feature of migraine attacks.5 Addition-
ally, a study showed that anomalies in the metabolism
of glutamate, γ-aminobutyric acid, and those that gov-
ern pain and vegetative functions, such as 5-HT, dopa-
mine (DA), and noradrenalin (NE), constituted the
phenotypical biochemical cause of the migraine.6 Based
on these studies, an acute blood stasis model was used
to assess the effect of QLTT on activating blood and
expelling blood stasis. A nitroglycerin-induced mi-
graine model was used to investigate the efficacy of
QLTT on plasma CGRP and β-EP, and a reserpine-in-
duced low 5-HT model was employed to explore the
effect of QLTT on plasma 5-HT concentrations and
the contents of 5-HT, DA, and NE in brain tissue.
MATERIALS ANDMETHODS
Preparation of QLTT
QLTT was manufactured in the pharmacy department
of Chinese People's Liberation Army General Hospital
(Beijing, China). It was prepared with 12 medicinal
herbs: 2 parts Huangqi (Radix Astragali Mongolici) and
Baishao (Radix Paeoniae Alba); 1.5 parts Danggui (Ra-
dix Angelicae Sinensis), Gegen (Radix Puerariae Loba-
tae) and Jili (Fructus Tribuli); 1.2 parts Chuanxiong
(Rhizoma Chuanxiong), Juhua (Flos Chrysanthemi) and
Dilong (Pheretima Aspergillum); and 1 part stir-frying
Gancao (Radix Glycyrrhizae), Ruxiang (Olibanum),
Moyao (Myrrh), and Tianma (Rhizoma Gastrodiae).
Herbs were purchased from Anguoshi Changda Chi-
nese Herbal Pieces Co., Ltd. (Hebei, China). All herbs
met the standards of the Chinese Pharmacopoeia
(2010 Edition, Volume I).7 Dilong (Pheretima Aspergil-
lum) and Moyao (Myrrh) were ground into a fine pow-
der and filtered through a 100 mesh. Jili (Fructus Tribu-
li) and Tianma (Rhizoma Gastrodiae) were pulverized
into a coarse powder and decocted with the other eight
herbs three times. The herbs were decocted with an
eight-fold volume of water for 1.5 h, then six-fold and
four-fold volumes of water for 1 h. The three decoc-
tions were filtered, mixed together and concentrated
under reduced pressure to a thick paste with relative
density 1.13 to 1.15 (50℃). The thick paste was dried
at 80℃ and ground into a fine powder with 100 mesh.
This powder was then mixed with the Dilong (Phereti-
ma Aspergillum) and Moyao (Myrrh) powder. Sucrose
and dextrin in the ratio of 2∶1 were also added. After
mixing evenly, all herbs were dried and packed. The
wet granulation technique was employed to prepare
QLTT and the yield of the extract was about 20%.
Reagents and apparatus
The following reagents and apparatus were used in the
experiment: Zhengtian pill (ZTP, China Resources San-
jiu Medical & Pharmaceutical Co., Ltd., Shenzhen,
China), adrenaline hydrochloride injection (Tianjin
Pharmaceutical Group Xinzheng Co., Ltd., Tianjin,
China), nitroglycerin injection (Beijing Yimin Pharma-
ceutical Co., Ltd., Beijing, China), trichloroacetalde-
hyde hydrate (Sinopharm Chemical Reagent Co., Ltd.,
Shanghai, China, analytical reagent), reserpine injec-
tion (Guangdong Bangmin Pharmaceutical Co., Ltd.,
Jiangmen, China), 5-Hydroxytryptamine hydrochlo-
ride (National Institute for the Control of Pharmaceuti-
cal and Biological Products, Beijing, China), noradren-
aline bitartrate (National Institute for the Control of
Pharmaceutical and Biological Products, Beijing, Chi-
na), dopamine hydrochloride (National Institute for
the Control of Pharmaceutical and Biological Prod-
ucts, Beijing, China), evacuated blood collection sys-
tem (Greiner Bio-One GmbH, Krems munster, Aus-
tria), Rheogeniometer SA-7000 (Beijing Sicceeder
Technology Development Co., Ltd., Beijing, China),
CGRP RIA kit (Beijing Huaying Biotechnology Re-
search Institute, Beijing, China), β-EP RIA kit (Bei-
jing Huaying Biotechnology Research Institute, Bei-
jing, China), phosphoric acid (Sinopharm Chemical
Reagent Co., Ltd., analytical reagent, Shanghai, Chi-
na), sodium heptanesulfonate (Sinopharm Chemical
Reagent Co., Ltd., analytical reagent, Shanghai, Chi-
na), acetonitrile (Fisher Scientific, Langenselbold, Ger-
many, spectrographic grade), Agilent Technologies Se-
ries 1200 system (Agilent, Santa Clara, CA, USA),
mouse 5-Hydroxytryptamine ELISA Kit (Beijing Aike
Boya Biotechnology Co., Ltd., Beijing, China), and
ELISA plate reader (Multiskan Ex Primary EIA V.2.3,
Thermo, Vantaa, Finland).
Animals
A total of 120 Sprague-Dawley rats (60 males and 60
females, 6-8 weeks old, 180-220 g, SPF) and 60 Kun-
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ming mice (30 males and 30 females, 2 months old,
23-27 g, SPF) were provided by the experimental ani-
mal center, Academy of Military Medical Sciences of
Chinese People's Liberation Army (Beijing, China, Cer-
tificate of quality No: SCXK- (jun) 2007-004). The
rats were housed four per cage (545 mm × 359 mm ×
200 mm) and mice were housed eight per cage. The
rats were kept at 22℃±2℃ with a 12-h light/dark cycle
(lights on at 8 a.m.) and had access to food and water
ad libitum. Animal welfare and experimental proce-
dures were carried out in accordance with international
ethical guidelines, and the trial was approved by the
ethics committee of Academy of Military Medical Sci-
ences of Chinese People's Liberation Army.
Acute blood stasis model test
Sixty Sprague-Dawley rats were randomly divided into
six groups by random number table method: (a) nor-
mal control group; (b) model group; (c) ZTP (1.62 g/
kg) group; (d) QLTT high-dose (3.6 g/kg) group; (e)
QLTT moderate-dose (1.8 g/kg) group; and (f ) QLTT
low-dose (0.9 g/kg) group. Rats were administered
drugs or tap water (normal and model groups) orally
once a day for 7 days. After the last gavage, rats in the
model group and medicine treatment groups were in-
jected with 0.1% adrenaline hydrochloride (0.8 mL/
kg, i.h.). After 2 h, the rats received a cold stimulation
in ice water for 5 min, and then an injection of an
equal amount of adrenaline hydrochloride was given.
After fasting for 12 h, rats were anesthetized with 10%
chloral hydrate (4 mL/kg, i.p.). Then, 3 mL blood per
rat was drawn from the postcava and collected in hepa-
rin anticoagulation tubes. The whole blood viscosity of
rats was detected by the Department of Laboratory
Medicine, Chinese People's Liberation Army General
Hospital.
Determination of plasma CGRP and β-EP in rats
with nitroglycerin-induced migraine
Sixty Sprague-Dawley rats were grouped with the same
method used for the acute blood stasis model rats. Rats
received the last gavage 1 h before injection of nitro-
glycerin (NTG, 10 mg/kg, i.p.) and were given prophy-
lactic treatment with corresponding medicine for the
previous 7 days. After 4 h, rats were anesthetized with
10% chloral hydrate (4 mL/kg, i.p.). Then, 2 mL
blood per rat was drawn from the postcava and collect-
ed in centrifuge tubes containing 7.5% ethylene di-
amine tetraacetic acid (EDTA, 30 µL) and aprotinin
(40 µL). Samples were separated by centrifugation
(4377 g) at 4℃ within 10 min and supernatants were
immediately stored at ﹣20℃ . The concentrations of
CGRP and β-EP were determined using respective
125I-CGRP and 125I-β-EP Radioimmunoassay Kits.
Reserpine-induced low 5-HT model test
Sixty Kunming mice were randomly divided into the
following six groups by random number table method:
(a) normal control group; (b) mode group; (c) ZTP
(2.34 g/kg) group; (d) QLTT (5.2 g/kg) group; (e)
QLTT moderate-dose (2.6 g/kg) group; and (f ) QLTT
low-dose (1.3 g/kg) group. Apart from the mice in the
normal control group, mice were administered reser-
pine (0.25 mg/kg, i.h.) once a day for 9 days. From the
third day of reserpine injection, mice in the normal
control group and model group were given tap water
orally, and medicine treatment groups were given corre-
sponding medications.
Blood clotting time
The assay of blood clotting time was carried out as
Chen et al. 8 After 1 h from the last reserpine injection
and gavage, blood samples were taken with glass capil-
lary tubes from the posterior orbital venous plexus of
mice, and a stopwatch was started immediately. A
small piece of capillary was broken from one end every
30 s until fibrin threads of blood appeared between the
broken ends of the glass capillary. Then the stopwatch
was stopped and the blood clotting time was recorded.
Plasma samples and cerebral homogenate samples
for 5-HT, DA, and NE determination
After completion of the blood clotting test, the eyeballs
of mice were taken out for the collection of blood sam-
ples. Then, brains were rapidly removed and cerebel-
lums were discarded. The remaining tissue samples
were weighed and stored at ﹣80℃ until homogeniza-
tion. Blood samples (0.5 mL) were collected in centri-
fuge tubes containing 7.5% EDTA (7.5 µL) and sepa-
rated by centrifugation (4377 ×g) at 4℃ within 10 min.
Supernatants were immediately stored at ﹣ 20℃ and
the concentrations of 5-HT were determined using
ELISA.
Per mouse, 0.1 g brain tissue was homogenized in 0.2 mL
perchloric acid (0.1 M), which included 0.01% cyste-
ine as an antioxidant. The homogenate was centrifuged
at 20 428 × g at 4℃ for 15 min, and 20 μL superna-
tant was directly injected into an Agilent 1200 series
HPLC equipped with a phenomenex luna C18 column
(250 mm × 4.6 mm × 5 μm). A VWD detector (Agi-
lent G1314B) was set at a wavelength of 280 nm. The
mobile phase consisted of 15 volumes of acetonitrile
and 85 volumes of 0.14% sodium heptanesulfonate
(adjusted to pH 3.0 with phosphoric acid). The col-
umn temperature was 40℃ and the flow rate was
1.0 mL/min.
Statistical analyses
Data are expressed as mean±standard deviation ( xˉ ±s).
All data analysis was tested by one-way analysis of vari-
ance (ANOVA). The least-significant difference (LSD)
test was used for the Post hoc multiple comparisons in
the data with homogeneity of variance and Dunnett's
T3 testing in the case of variance. The significance lev-
el was P<0.05. All data were analyzed with IBM SPSS
(version 19.0, SPSS Inc, Chicago, IL, USA).
190
JTCM |www. journaltcm. com April 15, 2014 |Volume 34 | Issue 2 |
Wu XF et al. / Experimental Study
RESULTS
Whole blood viscosity of acute blood stasis model rats
Compared with that of the normal control group, the
blood viscosity of the model group was significantly
higher. However, rats treated with ZTP and the high
(3.6 g/kg), moderate (1.8 g/kg), and low (0.9 g/kg)
doses of QLTT had significantly lower blood viscosity
than those of the control rats (Table 1).
Determination of the levels of CGRP and β-EP
As shown in Table 2, NTG stimulated the release of
CGRP and induced a decrease in plasma β-EP.
QLTT-treated rats at dosages of 3.6, 1.8 and 0.9 g/kg
as well as those treated with ZTP had lower NTG-in-
duced plasma CGRP levels. Apart from rats in the
QLTT (0.9 g/kg) group, the plasma β-EP levels in rats
of the other treatment groups were significantly higher
than those in the model rats.
Blood clotting time of reserpine-induce model mice
The time of blood coagulation was greatly shortened
by the administration of reserpine (Table 3). In this ex-
periment, QLTT at dosages of 5.2 and 2.6 g/kg and
ZTP significantly prolonged the clotting time com-
pared with the model group.
Group
Normal control
Model
ZTP (1.62 g/kg)
QLTT (3.6 g/kg)
QLTT (1.8 g/kg)
QLTT (0.9 g/kg)
n
9
10
9
10
8
8
Whole blood viscosity (mPa·S)
1/s
33.81±3.47a
46.40±4.91b
34.61±5.23a
35.34±3.57a
34.82±4.14a
36.31±5.74a
5/s
13.22±1.11a
17.65±1.49b
13.60±1.79a
13.84±1.18a
13.77±1.35a
14.29±1.80a
30/s
6.72±0.44a
8.65±0.61b
6.96±0.78a
7.06±0.50a
7.10±0.55a
7.33±0.69a
200/s
4.63±0.25a
5.89±0.35b
4.81±0.48a
4.87±0.29a
4.95±0.34a
5.08±0.39a
Table 1 Differences in whole blood viscosity of rats under different shear rates ( xˉ ±s)
Notes: normal control group treated with saline only; model group treated with saline and epinephrine; ZTP group treated with ZTP
(1.62 g/kg) and epinephrine; QLTT groups treated with epinephrine and high-dose QLTT (3.6 g/kg), moderate-dose QLTT (1.8 g/kg),
and low-dose QLTT (0.9 g/kg). ZTP: Zhengtian pill; QLTT: Qilongtoutong granule. Compared with model group, aP<0.01; compared
with the normal control group, bP<0.01.
Group
Normal control
Model
ZTP (1.62 g/kg)
QLTT (3.6 g/kg)
QLTT (1.8 g/kg)
QLTT (0.9 g/kg)
n
10
10
10
10
10
10
CGRP (pg/mL)
73±11a
92±5b
76±11a
77±10a
76±11a
82±8c
β-EP (pg/mL)
177±20a
149±14b
176±20a
182±22a
183±26a
165±21
Notes: normal control group treated with saline only; model group treated with saline and nitroglycerin; ZTP group treated with ZTP
(1.62 g/kg) and nitroglycerin; QLTT groups treated with nitroglycerin and high-dose QLTT (3.6 g/kg), moderate-dose QLTT (1.8 g/kg),
and low-dose QLTT (0.9 g/kg). ZTP: Zhengtian pill; QLTT: Qilongtoutong granule; CGRP: calcitonin gene-related peptide; β-EP: be-
ta-endorphin. Compared with model group, aP<0.01, cP<0.05; compared with normal control group, bP<0.01.
Table 2 Comparison of plasma CGRP and β-EP levels of rats ( xˉ ±s)
Group
Normal control
Model
ZTP (2.34 g/kg)
QLTT (5.2 g/kg)
QLTT (2.6 g/kg)
QLTT (1.3 g/kg)
n
10
9
9
10
9
9
Clotting time (s)
93±22
50±15
90±26
96±24
93±32
70±30
P value (vs normal control)
-
0.001
0.797
0.791
0.977
0.053
P value (vs model)
0.001
-
0.001
0.000
0.001
0.099
Table 3 Differences in blood clotting time of mice ( xˉ ±s)
Notes: normal control group treated with saline only; model group treated with saline and reserpine; ZTP group treated with ZTP (2.34 g/
kg) and reserpine; QLTT groups treated with reserpine and high-dose QLTT (5.2 g/kg), moderate-dose QLTT (2.6 g/kg), and low-dose
QLTT (1.3 g/kg). ZTP: Zhengtian pill; QLTT: Qilongtoutong granule.
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Contents of 5-HT, NE, and DA in plasma and brain
tissue of mice
Compared with the model group, QLTT- (2.6 g/kg)
and ZTP-treated mice had significantly higher plasma
5-HT levels (P<0.05). Meanwhile, QLTT- (5.2, 2.6
and 1.3 g/kg) and ZTP-treated mice had significantly
higher 5-HT, NE, and DA contents in the brain tissue
(P<0.01) than those in model mice, although they
were not as high as those in the normal mice. Typical
high-performance liquid chromatography chromato-
grams of brain homogenate for detecting the 5-HT,
NE, and DA concentrations are shown in Figure 1 and
Table 4.
DISCUSSION
Our studies demonstrated that rats treated with QLTT
at the high, moderate, and low dosages, and ZTP, had
lower whole blood viscosity than those in blood stasis
model rats under different shear rates. Treated rats also
had longer clotting times than those in reserpine-in-
duced model mice. CGRP is considered an important
mediator in migraine and has been found at increased
concentrations in peripheral blood plasma during at-
tacks of migraine.9 Meanwhile, some studies indicated
that migraine is closely related to the impairment of
the endogenous opioid peptide system, and especially
Group
Normal control
Model
ZTP
QLTT
QLTT
QLTT
Dosage
(g/kg)
-
-
2.34
5.20
2.60
1.30
Plasma serotonin
(ng/mL)
259±98a
107±56b
191±90c
180±75d
194±84c
145±66b
Brain tissue (ng/g)
Serotonin
556±44a
268±34b
358±45ab
353±33ab
353±32ab
305±36bc
Noradrenalin
675±47a
279±34b
358±42ab
367±31ab
367±30ab
315±36bc
Dopamine
2042±250a
510±45b
978±130ab
985±158ab
988±141ab
675±47ba
Table 4 Differences in serotonin, noradrenalin, and dopamine contents in plasma and brain tissue in mice (n=10, xˉ ±s)
Notes: normal control group treated with saline only; model group treated with saline and reserpine; ZTP group treated with ZTP (2.34 g/
kg) and reserpine; QLTT groups treated with reserpine and high-dose QLTT (5.2 g/kg), moderate-dose QLTT (2.6 g/kg), and low-dose
QLTT (1.3 g/kg). ZTP: Zhengtian pill; QLTT: Qilongtoutong granule. Compared with model group, aP<0.01, cP<0.05; compared with
normal control group, bP<0.01, dP<0.05.
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Figure 1 High-performance liquid chromatography chromatograms of brain homogenate
A: normal control group, treated with saline only; B: model group, treated with saline and reserpine; C: Zhengtian pill group, treat-
ed with ZTP (2.34 g/kg) and reserpine; D: Qilongtoutong high-dose (5.2 g/kg) group, treated with QLTT (5.2 g/kg) and reserpine; E:
Qilongtoutong moderate-dose (2.6 g/kg) group, treated with QLTT (2.6 g/kg) and reserpine; F: Qilongtoutong low-dose (1.3 g/kg)
group, treated with QLTT (1.3 g/kg) and reserpine.
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that the disturbance of beta-endorphin may give rise to
regulation disorders of afferent nociception.10 Plasmaβ-EP levels are remarkably low in migraine patients
and there is an inverse relationship between endorphin
levels and headache severity scores.11 To investigate the
influence of QLTT on plasma CGRP and β-EP, a reli-
able animal experimental migraine model induced by
NTG was chosen.12 The rats showed a series of symp-
toms after being injected with NTG, which are similar
to the symptoms of human migraine onset. The symp-
toms include frequent scratching of the head, climbing
cages and flushing. These typical manifestations of mi-
graine were used as indicators of successful models es-
tablishment.13 We found that QLTT-treated rats had
significantly lower plasma CGRP levels and higher plas-
ma β-EP levels than those in model rats.
Among the many neurotransmitters in the brain,
5-HT from the brainstem raphe nucleus has been most
convincingly implicated in migraine.14 Some research-
ers also hypothesize that 5-HT dysfunction in the cir-
culatory system is involved in the pathogenesis of mi-
graine.15 Recent evidence suggests that a low level of
5-HT facilitated activation of the trigeminovascular no-
ciceptive pathway.14 One study also showed that norepi-
nephrine inhibited the migration of a cortical spread-
ing depression wave in the adult gray matter.16 Addi-
tionally, dopamine appears to have a beneficial effect
on pain by inhibiting nociceptive transmission from
the trigeminocervical complex up to the thalamus.17
Many studies indicate that 5-HT, NE, and DA play an
important role in migraine onset. However, reserpine
can deplete monoamine neurotransmitters and precipi-
tate migraine onset.18 In our experiments, mice treated
with QLTT at high, moderate, and low doses, and
ZTP, had higher 5-HT levels than those in model mice
with migraine induced by reserpine. This suggests that
QLTT and ZTP rely on the serotonergic system and ty-
rosine metabolism pathway to relieve the pain caused
by migraine. To ease the pain, QLTT might act
through multiple pathways including activating blood,
expelling blood stasis, and regulating the levels of
CGRP, β-EP, 5-HT, NE, and DA. However, further
study is needed to elucidate the QLTT mechanism un-
derpinning its pain-relieving action.
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